TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Investor Investigation Over Potential Breaches Of Fiduciary Duties Announced

  • If you are a current long term stockholder of shares of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Threshold Pharmaceuticals
Security
NASDAQ: THLD

Summary

April 9, 2013 (Shareholders Foundation ) - An investigation on behalf of investors in shares of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) was announced concerning whether certain Threshold Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements.

The investigation by a law firm concerns, among other things, whether certain Threshold Pharmaceuticals officers and directors breached their fiduciary duties and caused damage to the company and its shareholders by failing to implement adequate internal controls.

Threshold Pharmaceuticals, Inc. reported that its annual Total Revenue rose from $0.06 million in 2011 to $5.87 million in 2012. However, its Net Loss increased from $25.65 million in 2011 to $71.14 million in 2012.

Shares of Threshold Pharmaceuticals, Inc. grew from $1.36 per share in Janaury 2012 to as high as $8.94 per share in September 2012 but declined to as low as $3.98 per share in November 2012.

On April 9, 2013, NASDAQ:THLD shares closed at $4.60 per share.

Start Monitoring Your Investments